• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与社区队列中肺功能下降及呼吸道症状和疾病相关的健康结局。

Health outcomes associated with lung function decline and respiratory symptoms and disease in a community cohort.

机构信息

National Institute for Occupational Safety and Health, Division of Respiratory Disease Studies, Surveillance Branch, Morgantown, West Virginia 26505, USA.

出版信息

COPD. 2011 Apr;8(2):103-13. doi: 10.3109/15412555.2011.558544.

DOI:10.3109/15412555.2011.558544
PMID:21495838
Abstract

BACKGROUND

In workplace respiratory disease prevention, a thorough understanding is needed of the relative contributions of lung function loss and respiratory symptoms in predicting adverse health outcomes.

METHODS

Copenhagen City Heart Study respiratory data collected at 4 examinations (1976-2003) and morbidity and mortality data were used to investigate these relationships. With 15 or more years of follow-up for a hospital diagnosis of chronic obstructive pulmonary disease (COPD) morbidity, COPD or coronary heart disease (CHD) mortality, and all-cause mortality, risks for these outcomes were estimated in relation to asthma, chronic bronchitis, shortness of breath, and lung function level at examination 2 (1981-1983) or lung function decline established from examinations 1 (1976-1978) to 2 using 4 measures (FEV(1) slope, FEV(1) relative slope, American College of Occupational and Environmental Medicine's Longitudinal Normal Limit [LNL], or a limit of 90 milliliters per year [ml/yr]). These risks were estimated by hazard ratios (HR) and 95% confidence intervals (CI) adjusted for age, height-adjusted baseline forced expiratory volume in 1 second (FEV(1)/height(2)), and height.

RESULTS

For COPD morbidity, the increasing trend in the HR (95% CI) by quartiles of the FEV(1) slope reached a maximum of 3.77 (2.76-5.15) for males, 6.12 (4.63-8.10) for females, and 4.14 (1.57-10.90) for never-smokers. Significant increasing trends were also observed for mortality, with females at higher risk.

CONCLUSION

Lung function decline was associated with increased risk of COPD morbidity and mortality emphasizing the need to monitor lung function change over time in at-risk occupational populations.

摘要

背景

在工作场所呼吸疾病预防中,需要深入了解肺功能丧失和呼吸症状在预测不良健康结果方面的相对贡献。

方法

使用哥本哈根城市心脏研究在 4 次检查(1976-2003 年)中收集的呼吸数据和发病和死亡率数据,来研究这些关系。对于慢性阻塞性肺疾病(COPD)发病、COPD 或冠心病(CHD)死亡和全因死亡率的 15 年以上随访,使用 4 种措施(FEV(1)斜率、FEV(1)相对斜率、美国职业与环境卫生医学学院的纵向正常限值[LNL]或每年 90 毫升的限值[ml/yr])从第 1 次(1976-1978 年)至第 2 次检查(1981-1983 年)建立的肺功能下降,或从第 1 次(1976-1978 年)至第 2 次检查(1981-1983 年)的肺功能水平,估计这些结果与哮喘、慢性支气管炎、呼吸困难和第 2 次检查(1981-1983 年)的肺功能之间的相关性。使用风险比(HR)和 95%置信区间(CI)来调整年龄、身高校正后的第 1 秒用力呼气量(FEV(1)/身高(2))和身高。

结果

对于 COPD 发病,男性第 1 秒用力呼气量(FEV(1))斜率四分位 HR(95%CI)呈上升趋势,最高值为 3.77(2.76-5.15),女性最高值为 6.12(4.63-8.10),从不吸烟者最高值为 4.14(1.57-10.90)。死亡率也观察到显著的上升趋势,女性风险更高。

结论

肺功能下降与 COPD 发病和死亡风险增加相关,强调需要在高危职业人群中监测随时间的肺功能变化。

相似文献

1
Health outcomes associated with lung function decline and respiratory symptoms and disease in a community cohort.与社区队列中肺功能下降及呼吸道症状和疾病相关的健康结局。
COPD. 2011 Apr;8(2):103-13. doi: 10.3109/15412555.2011.558544.
2
Lung function decline and outcomes in an adult population.成年人群的肺功能下降及预后
Am J Respir Crit Care Med. 2006 May 1;173(9):985-90. doi: 10.1164/rccm.200508-1344OC. Epub 2006 Jan 26.
3
Influence of chronic obstructive pulmonary disease on postoperative lung function and complications in patients undergoing operations for primary non-small cell lung cancer.慢性阻塞性肺疾病对原发性非小细胞肺癌手术患者术后肺功能及并发症的影响。
J Thorac Cardiovasc Surg. 2007 Nov;134(5):1292-9. doi: 10.1016/j.jtcvs.2007.07.038.
4
The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding.以患者为中心的结局在慢性阻塞性肺疾病病程中的作用:长期研究如何增进我们的理解。
Am J Med. 2006 Oct;119(10 Suppl 1):63-72. doi: 10.1016/j.amjmed.2006.08.009.
5
Epidemiological studies in mucus hypersecretion.
Novartis Found Symp. 2002;248:3-12; discussion 12-9, 277-82.
6
Impact of tiotropium on the course of moderate-to-very severe chronic obstructive pulmonary disease: the UPLIFT trial.噻托溴铵对中重度至极重度慢性阻塞性肺疾病病程的影响:UPLIFT 试验。
Expert Rev Respir Med. 2010 Jun;4(3):279-89. doi: 10.1586/ers.10.23.
7
Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD.改良版GOLD 1期慢性阻塞性肺疾病患者的肺功能、医疗服务利用情况及生活质量的长期下降
Thorax. 2008 Sep;63(9):768-74. doi: 10.1136/thx.2007.093724. Epub 2008 May 27.
8
Decline in FEV1 in relation to incident chronic obstructive pulmonary disease in a cohort with respiratory symptoms.有呼吸道症状队列中,第一秒用力呼气容积(FEV1)下降与慢性阻塞性肺疾病发病的关系
COPD. 2007 Mar;4(1):5-13. doi: 10.1080/15412550601168358.
9
A 4-year trial of tiotropium in chronic obstructive pulmonary disease.噻托溴铵用于慢性阻塞性肺疾病的4年试验。
N Engl J Med. 2008 Oct 9;359(15):1543-54. doi: 10.1056/NEJMoa0805800. Epub 2008 Oct 5.
10
Chronic obstructive pulmonary disease and hospitalizations for pneumonia in a US cohort.美国队列中的慢性阻塞性肺疾病与肺炎住院情况
Respir Med. 2009 Feb;103(2):224-9. doi: 10.1016/j.rmed.2008.09.005. Epub 2008 Oct 21.

引用本文的文献

1
Epigenetic Features in Newborns Associated with Preadolescence Lung Function and Asthma Acquisition during Adolescence.新生儿的表观遗传特征与青春期前肺功能及青春期哮喘发病的关联
Epigenomes. 2024 Mar 22;8(2):12. doi: 10.3390/epigenomes8020012.
2
Pubertal onset with adulthood lung function mediated by height growth in adolescence.青春期身高增长介导青春期启动与成年期肺功能。
ERJ Open Res. 2020 Nov 10;6(4). doi: 10.1183/23120541.00535-2020. eCollection 2020 Oct.
3
Gene network analysis in a pediatric cohort identifies novel lung function genes.
基因网络分析在儿科队列中鉴定出新型肺功能基因。
PLoS One. 2013 Sep 2;8(9):e72899. doi: 10.1371/journal.pone.0072899. eCollection 2013.
4
Combined effect of lung function level and decline increases morbidity and mortality risks.肺功能水平和下降的综合影响增加了发病和死亡风险。
Eur J Epidemiol. 2012 Dec;27(12):933-43. doi: 10.1007/s10654-012-9750-2. Epub 2012 Dec 14.